- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04119752
Effect of Curcumin on Microvascular Response and Tissue Oxygenation
Effect of Curcumin on Microvascular Response and Tissue Oxygenation in Older People
Aging has been associated with reduced bioavailability of nitric oxide(NO) and endotelial dysfunction.Curcumin, a phenolic compound present in the rhizomes of turmeric, possesses cardiovascular protective, anti-inflammatory and antioxidante properties.
The present study is evaluating the effects of ingestion of 10 g of curcumin supplementation (CUR) on microvascular responsiveness and tissue oxygen saturation in the elderly with cardiometabolic risks.Twenty eight older individuals have been submitted to 10 g of curcumin suplementation (CUR) or placebo (PLA) (sucralose). Microvascular responsiveness and tissue oxygen saturation have been measured 120 minutes after interventions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aging has been associated with reduced bioavailability of nitric oxide(NO) and endotelial dysfunction.
Curcumin, a phenolic compound present in the rhizomes of turmeric, possesses cardiovascular protective, anti-inflammatory and antioxidante properties.
The present study is evaluating the effects of ingestion of 10 g of curcumin suplementation(CUR) on endothelial function and muscle oxygen saturation in the elderly at cardiometabolic risks.
The study is randomized, crossed-over, double blind and controlled by placebo.Twenty-eight volunteers have been recruted for the research. They will perform three visits in vascular dymamic laboratory, that is located at the Federal Universite of Rio de Janeiro , campus Macaé. Basic measures have been performed on the first visit: systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR), maximal voluntary contraction (MVC), endothelial function analysis, vascular responsiveness during rest ( TOV) and rhythmic handgrip exercise. On second and third visits, after 10 minutes period of quiet in rest , volunteers are submitted (SBP), (DBP) and (HR), MVC, blood and urine samples are drawn at baseline in order to analyse curcumin absorption and verify oxidative stress markers( vitamin C and malondialdehyde). Moreover , volunteers are submitted to 10 g of curcumin supplementation (CUR) diluted in 400 ml cold water or placebo (sucralose) that is offered in capsules ingested with 400 ml of water. Microvascular responsiveness and muscle oxygen saturation have been is measured 120 minutes after intervention.Urine and blood samples have been drawn again 20 minutes after exercise.
Before each visit, participants are instructed to fast 8 hours avoiding ingestion of high nitrate such as ( sausages, cheeses, dark green leaves, beets), polifenols foods ( tea, coffee, grape juice and cocoa) and curcumin based dressings(turmeric, curry, colorau). Also, participants have been instructed not practice plysical activities and not change food habits during the research period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rio De Janeiro
-
Macaé, Rio De Janeiro, Brazil
- Central Coexistence of the Elderly
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Seniors,
- With two or more risk factors for cardiovascular disease:Dyslipidemia, visceral obesity, hypertension, diabetes mellitus 2 and others.
Exclusion Criteria:
- Smoking,
- Use of antioxidant drugs during the experiment period,
- Allergy to components of curcumin,
- With previous history of cancer, HIV,
- Neurodegenerative and osteomioarticular diseases.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Curcumin powder
Curcumin powder - 10g
|
10g of curcumin powder
|
Placebo Comparator: Placebo ( curcumin depleted)
Placebo- sucralose -1g
|
1g of sucralose
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in microvascular reactivity
Time Frame: Changes from baseline at 120 minutes after nutritional intervention
|
Microvascular reactivity will be evaluated by using a near-infrared spectroscopy device during a vascular occlusion test.
|
Changes from baseline at 120 minutes after nutritional intervention
|
Changes in tissue oxygen saturation
Time Frame: Changes from baseline at 120 minutes after nutritional intervention
|
Muscle and cerebral oxygen saturation will be evaluated by using a near-infrared spectroscopy device during exercise
|
Changes from baseline at 120 minutes after nutritional intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in nitric oxide metabolites (plasma nitrate and nitrite)
Time Frame: Changes from baseline at 120 minutes after nutritional intervention
|
Nitric oxide metabolites will be evaluated by plasma nitrate and nitrite by using a high-performance liquid chromatography system.
|
Changes from baseline at 120 minutes after nutritional intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Cristina Rezende, UFRJ -Campus Macaé
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Antineoplastic Agents
- Curcumin
Other Study ID Numbers
- 97055018.1.0000.5699
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Curcumin powder
-
ESM Technologies, LLCThe University of Texas Health Science Center, HoustonEnrolling by invitation
-
Aimmune Therapeutics, Inc.TerminatedHen Egg AllergyUnited States
-
Mukuba UniversityUniversity of Stellenbosch; Medical Research Council, South AfricaCompleted
-
Tata Memorial HospitalPharmanza Herbals Pvt Limited (PHPL)Unknown
-
RiboCor, Inc.Completed
-
University of California, BerkeleyUniversity of California, DavisActive, not recruitingConsumption | Side Effect | AcceptabilityUnited States
-
H.K.E.S's S.Nijalingappa Institute of Dental Science...Unknown
-
GlaxoSmithKlineCompleted
-
Université de SherbrookeUnknown
-
Kantonsspital AarauTerminatedUrinary Tract InfectionsSwitzerland